Disappointed by the revenue, when are all our esteemed international 'partners' going to start paying for what we do for them. I thought completion of the last POC1 study/project was meant to net $250,000 per scientist?
Having said that, the future is beginning to look more exciting than ever with a reasonable cash runway to realise cashflow positive operations.
Also no mention of acquisition developments - or did I scan read it too quickly?
Ann: Appendix 4C March 2015 Quarterly, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(3.67%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $7.812K | 349.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 828094 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 1102151 | 4 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |